NEW ZEALAND GAZETTE, No. 65

19 JUNE 2014

• Cyclizine; except when specified elsewhere in this notice

• Dabrafenib mesilate

• Dapagliflozin propanediol

• Degarelix

• Denosumab

• Diclofenac; in preparations for the treatment of solar keratosis; except when specified elsewhere in this notice; except in preparations for external use other than for the treatment of solar keratosis

• Dimethyl fumarate

• Diphtheria, tetanus and pertussis (acellular, component) vaccine; except when administered in a single dose to a person 18 years of age or over by a registered pharmacist who has successfully completed a vaccinator training course approved by the Ministry of Health and who is complying with the immunisation standards of the Ministry of Health

• Dolutegravir

• Dronedarone

• Econazole; except in medicines for vaginal or dermal use

• Eculizumab

• Elvitegravir

• Enobosarm

• Enzalutamide

• Eribulin mesylate

• Febuxostat

• Ferric carboxymaltose

• Fidaxomicin

• Fingolimod

• Follistatin

• Ghrelin

• Glycopyrronium

• Guaiphenesin; for oral use in medicines containing more than 2% or 200 milligrams per dose form except when specified elsewhere in this notice; except for oral use in modified release form with a maximum recommended daily dose of not more than 2.4 grams when sold in the manufacturer’s original pack containing not more than 10 days’ supply

• Hexarelin

• Icatibant

• Human growth hormone secretagogues

• Indacaterol

• Influenza vaccine; except when administered to a person 18 years of age or over by a registered pharmacist who has successfully completed a vaccinator training course approved by the Ministry of Health and who is complying with the immunisation standards of the Ministry of Health

• Ingenol mebutate

• Insulin-like growth factors; except where specified elsewhere in this notice

• Ipamorelin

• Ipilimumab

• Isoconazole; except in medicines for vaginal or dermal use

• Ivacaftor

• Linagliptin

• Lixisenatide

• Loteprednol

• Loteprednol etabonate

• Lovastatin; except when present as an unmodified, naturally occurring substance in a food that has not been subject to a manufacturing process other than heating, freezing, drying, preserving, bottling, canning or packaging in retort pouches

• Lurasidone

• Macitentan

• Melanocyte stimulating compounds

• Meningococcal vaccine; except when administered to a person 16 years of age or over by a registered pharmacist who has successfully completed a vaccinator training course approved by the Ministry of Health and who is complying with the immunisation standards of the Ministry of Health

• Mercurochrome; except when specified elsewhere in this notice

• Micafungin

• Miconazole; except when specified elsewhere in this notice; except in medicines for tinea pedis only or when sold in practice by a podiatrist registered with the Podiatrists Board

• Mirabegron

• Nitisinone

• Nitrous Oxide; when supplied for inhalation

• Nomegestrol

• Nystatin; except when specified elsewhere in this notice; except in medicines for tinea pedis only or when sold in practice by a podiatrist registered with the Podiatrists Board

• Obinutuzumab

• Ocriplasmin

• Ofatumumab

• Olodaterol

• Omeprazole; except when specified elsewhere in this notice

• Oseltamivir; except when specified elsewhere in this notice

• Pantoprazole; except when specified elsewhere in this notice

• Pasireotide

• Pasireotide diaspartate

• Pertuzumab

• Pitavastatin

• Plerixafor

• Pradofloxacin

• Pralatrexate

• Prucalopride

• Pseudoephedrine

• Ranitidine; except when specified elsewhere in this notice; except in medicines containing 150 milligrams or less per dose unit when sold in the manufacturer’s original pack containing not more than 7 days’ supply

• Regorafenib

• Remestemcel-L

• Retapamulin

• Retigabine

• Ridaforolimus

• Rifaximin

• Rilpivirine

• Romidepsin

• Rupatadine

• Ruxolitinib

• Sapropterin

• Selective androgen receptor modulators

• Simeprevir

• Sofosbuvir

• Tafluprost

• Taliglucerase alfa